SGS
CELG

Sterling Global Strategies’s Celgene Corp CELG Stock Holding History

Sterling Global Strategies’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,000
Closed -$240K – 28
2015
Q4 		$240K Buy
+2,000
New +$231K 3.81% 16

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Sterling Global Strategies's CELG Position: Q1 2016 in Review

Sterling Global Strategies sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 2,000 shares — an estimated $240K sold.

Sterling Global Strategies first reported a position in CELG in Q4 2015 and held it in 1 quarter. The position peaked at $240K in Q4 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • Sterling Global Strategies reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
  • Sterling Global Strategies sold 2,000 Celgene Corp shares in Q1 2016, an estimated $240K.
  • Sterling Global Strategies first reported a position in Celgene Corp in Q4 2015 and held it in 1 quarter.
  • Sterling Global Strategies's Celgene Corp position peaked at $240K in Q4 2015.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Sterling Global Strategies's 13F filing for Q1 2016, filed 16 May 2016.